<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>56</volume><submitter>Chehrazi-Raffle A</submitter><journal>EBioMedicine</journal><pagination>102812</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7276505</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?</pubmed_title><pmcid>PMC7276505</pmcid><pubmed_authors>Pal SK</pubmed_authors><pubmed_authors>Chehrazi-Raffle A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-04T07:31:47.631Z</modification><creation>2025-04-04T07:31:47.631Z</creation></dates><accession>S-EPMC7276505</accession><cross_references><pubmed>32512515</pubmed><doi>10.1016/j.ebiom.2020.102812</doi></cross_references></HashMap>